Baxter International Faces Class Action Lawsuit Over Novum LVP Product Malfunctions
- Baxter International faces a class action lawsuit over safety and reliability issues with its Novum LVP product line.
- Allegations suggest Baxter misled shareholders about Novum LVP defects leading to severe patient risks and malfunctions.
- The lawsuit highlights concerns about Baxter's accountability and the impact on patient safety and corporate reputation.
Baxter International Faces Class Action Lawsuit Over Novum LVP Product Malfunctions
Baxter International Inc. is currently embroiled in a potential class action lawsuit that raises serious questions about the safety and reliability of its Novum LVP product line. The Gross Law Firm has issued a notice to shareholders who acquired shares from February 23, 2022, to July 30, 2025, inviting those affected to consider their eligibility for lead plaintiff status in the case. Allegations indicate that Baxter issued misleading information regarding the Novum LVPs, which are designed to deliver intravenous fluids to patients. Reports claim that these devices exhibited systemic defects, resulting in dangerous malfunctions such as underinfusion, overinfusion, and total non-delivery of fluids, which pose significant risks to patient safety.
According to the complaint, Baxter was allegedly aware of multiple failures associated with the Novum LVP devices, including instances that led to severe patient injuries and fatalities. The lawsuit contends that the company neglected to take adequate remedial actions despite this knowledge, potentially halting new sales and prompting the withdrawal of existing devices from the market. The gravity of these allegations raises concerns not only for the company's reputation but also for the overall trust in medical devices that are critical for patient care. The claims assert that Baxter's representations about the safety and efficacy of the Novum LVPs were materially misleading, which could have lasting implications for both the company and its stakeholders.
The class action lawsuit serves as a reminder of the heightened scrutiny that medical device manufacturers face, particularly in an industry where patient safety is paramount. As regulatory bodies continue to monitor such claims closely, Baxter must navigate the legal ramifications while striving to restore confidence in its products. Shareholders wishing to engage with the lawsuit have until December 15, 2025, to register for participation, with no cost or obligation involved. The Gross Law Firm emphasizes that affected parties should take action to protect their rights and stay informed about the case's developments.
In addition to the legal challenges, Baxter International must also contend with the implications of these allegations on its product lines and overall market position. The company’s response to the allegations can significantly affect its reputation and operational viability in the highly competitive healthcare landscape. shareholder engagement in this process could provide insights into shareholder sentiment and the importance of accountability in corporate governance.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

